Cargando…

Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson's Disease in Response to Antiparkinsonian Drugs

Little is known about the relationship between regional cerebral blood flow (rCBF) change and clinical improvement in patients with Parkinson's disease (PD). Single-photon emission computed tomography (SPECT) measurement of cerebral blood flow allows evaluation of temporal changes in brain func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taguchi, Soutarou, Tanabe, Nachi, Niwa, Jun-ichi, Doyu, Manabu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421789/ https://www.ncbi.nlm.nih.gov/pubmed/30944721 http://dx.doi.org/10.1155/2019/7503230

Ejemplares similares

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease
por: Taguchi, Soutarou, et al.
Publicado: (2021)

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
por: Silva, Sara, et al.
Publicado: (2021)

Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson’s Disease
por: SAMURA, Kazuhiro, et al.
Publicado: (2019)

Multiple cerebral infarctions due to calcified amorphous tumor growing rapidly from an antecedent infection and decreasing rapidly by detachment of fibrin and antithrombotic drugs: a case report
por: Kimura, Motoya, et al.
Publicado: (2022)

A STUDY OF PROPHYLACTIC VALUE OF ANTIPARKINSONIAN DRUG
por: Behere, P.B., et al.
Publicado: (1983)

Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication
por: Chung, Jae Woo, et al.
Publicado: (2017)

Antiparkinsonian medication masks motor signal progression in de novo patients()
por: Brzezicki, Maksymilian A., et al.
Publicado: (2023)

Antipsychotics dosage and antiparkinsonian prescriptions
por: Acquaviva, Eric, et al.
Publicado: (2007)

Recurring Weakness in Rhabdomyolysis Following Pfizer–BioNTech Coronavirus Disease 2019 mRNA Vaccination
por: Kimura, Motoya, et al.
Publicado: (2022)

Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis
por: Nimmons, Danielle, et al.
Publicado: (2021)

Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2011)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
por: Miguelez, Cristina, et al.
Publicado: (2017)

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
por: Massari, Caio M., et al.
Publicado: (2017)

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
por: Paccione, Nicola, et al.
Publicado: (2022)

Rapid preparation process of antiparkinsonian drug Mucuna pruriens silver nanoparticle by bioreduction and their characterization
por: Arulkumar, Subramanian, et al.
Publicado: (2010)

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
por: Pitcher, T. L., et al.
Publicado: (2014)

Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets
por: Michel, Anne, et al.
Publicado: (2017)

Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease
por: Pelizzari, Laura, et al.
Publicado: (2019)

LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs
por: Beliakov, Sergei V., et al.
Publicado: (2023)

The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate
por: Lieu, Christopher A., et al.
Publicado: (2012)

Time until modification of antiparkinsonian therapy in a group of patients from Colombia
por: Valencia-Vásquez, Aníbal, et al.
Publicado: (2023)

A 47-Year-Old Japanese Woman with Symptoms of Increased Salty and Reduced Sweet Taste Perception Preceding a Diagnosis of Thymoma-Associated Myasthenia Gravis
por: Kimura, Motoya, et al.
Publicado: (2022)

Effects of tDCS dose and electrode montage on regional cerebral blood flow and motor behavior
por: Shinde, Anant B, et al.
Publicado: (2021)

1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
por: Ortíz de Zárate, Ana, et al.
Publicado: (2021)

Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin
por: Guo, Chen-hong, et al.
Publicado: (2020)

c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism
por: Zhou, Yu, et al.
Publicado: (2018)

A Method for the Estimation of Regional Cerebral Blood Flow
por: Knapp, F. M., et al.
Publicado: (1955)

Changes in cerebral blood flow during forward and backward walking with speed misperception generated by virtual reality
por: Takami, Akiyoshi, et al.
Publicado: (2021)

Changes in cerebral oxygen saturation and cerebral blood flow velocity under mild +Gz hypergravity
por: Konishi, Toru, et al.
Publicado: (2019)

Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
por: Bohnen, Nicolaas I, et al.
Publicado: (2021)

The 5-HT(2A) Receptor Antagonist M100907 Produces Antiparkinsonian Effects and Decreases Striatal Glutamate
por: Ansah, Twum A., et al.
Publicado: (2011)

Association of Blood Pressure, White Matter Lesions, and Regional Cerebral Blood Flow
por: Zhang, Dong, et al.
Publicado: (2021)

Rapid-onset dystonia-parkinsonism is associated with reduced cerebral blood flow without gray matter changes
por: Whitlow, Christopher T., et al.
Publicado: (2023)

Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression
por: Qiu, Juan, et al.
Publicado: (2014)

Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans
por: Martins, D. A., et al.
Publicado: (2020)

Changes of regional cerebral blood flow after deep brain stimulation in cervical dystonia
por: Park, Sungjin, et al.
Publicado: (2022)

Discriminative pattern of reduced cerebral blood flow in Parkinson’s disease and Parkinsonism-Plus syndrome: an ASL-MRI study
por: Cheng, Lina, et al.
Publicado: (2020)

Cerebral Microcirculatory Blood Flow Dynamics During Rest and a Continuous Motor Task
por: Müller, Martin, et al.
Publicado: (2019)

The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database
por: Johannes, Catherine B., et al.
Publicado: (2022)

Altered Regional Cerebral Blood Flow in Chronic Whiplash Associated Disorders
por: Vállez García, David, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n2kj17bmoo4f1c7q5nktc9r131